Área Sanitaria de Ourense, Verín e O Barco de Valdeorras
Área sanitaria
University of Lorraine
Nancy, FranciaPublicacións en colaboración con investigadores/as de University of Lorraine (1)
2022
-
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
The Lancet Diabetes and Endocrinology, Vol. 10, Núm. 1, pp. 35-45